Cetwis-M Tablet
By Cetwis-M
Rx
10 Tablet in a Strip

Composition
Levocetirizine(5mg) + Montelukast(10mg)

Manufacturer - Medilewis Biotech
Scf 313/314, 1St & 2Nd Floor Motor Market, Mani Majra, Chandigarh

Expires on or after
September, 2025

liver
When using Cetwis-M Tablet, it is important to use caution if you have severe liver disease. Your doctor may need to adjust the dosage of the medication in such cases. It is advisable to consult with your healthcare provider before starting or changing the dosage of Cetwis-M Tablet if you have severe liver issues. There is limited information available regarding the use of this medication in patients with severe liver disease. However, no dose adjustment is typically needed for individuals with mild to moderate liver disease. It is essential to follow your doctor's guidance closely to ensure the safe and effective use of Cetwis-M Tablet.

kidney
Caution should be taken when using Cetwis-M Tablet in patients with kidney disease. Dose adjustment may be necessary. Avoid use in severe kidney disease. Consult your doctor for guidance.

alcohol
When taking Cetwis-M Tablet, it is important to be cautious when consuming alcohol. It is advised to consult your doctor regarding alcohol consumption while on this medication.

driving
When taking Cetwis-M Tablet, be cautious as it may reduce alertness, cause vision changes, or induce drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
During pregnancy, it is generally believed that Cetwis-M Tablet is safe to use as it has shown minimal adverse effects in animal studies. However, there is limited research on its effects in humans.

breastfeeding
Cetwis-M Tablet is not recommended for use during breastfeeding as it may be toxic to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹102
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024